Strategic Global Advisors LLC Has $1.28 Million Holdings in Colgate-Palmolive Company $CL

Strategic Global Advisors LLC cut its stake in Colgate-Palmolive Company (NYSE:CL) by 69.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,950 shares of the company’s stock after selling 32,280 shares during the period. Strategic Global Advisors LLC’s holdings in Colgate-Palmolive were worth $1,279,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Odyssean LLC grew its stake in shares of Colgate-Palmolive by 236.0% during the second quarter. Odyssean LLC now owns 13,316 shares of the company’s stock valued at $1,221,000 after purchasing an additional 9,353 shares during the last quarter. Man Group plc lifted its holdings in Colgate-Palmolive by 6.6% during the 2nd quarter. Man Group plc now owns 966,992 shares of the company’s stock worth $88,654,000 after buying an additional 60,041 shares in the last quarter. Valtrion Capital Management LLC lifted its holdings in Colgate-Palmolive by 4.3% during the 2nd quarter. Valtrion Capital Management LLC now owns 3,568 shares of the company’s stock worth $327,000 after buying an additional 146 shares in the last quarter. Polar Asset Management Partners Inc. bought a new position in Colgate-Palmolive in the 2nd quarter valued at $306,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Colgate-Palmolive in the 2nd quarter valued at $9,826,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $92.12 on Thursday. The firm has a fifty day moving average of $91.98 and a two-hundred day moving average of $90.08. The company has a debt-to-equity ratio of 13.82, a quick ratio of 0.67 and a current ratio of 1.03. The stock has a market capitalization of $73.44 billion, a price-to-earnings ratio of 36.56, a PEG ratio of 4.27 and a beta of 0.33. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.The business had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. During the same period last year, the company earned $0.92 EPS. The firm’s revenue was up 4.9% on a year-over-year basis. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.86 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Monday, July 20th were issued a dividend of $0.53 per share. The ex-dividend date was Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is 84.13%.

Analysts Set New Price Targets

CL has been the subject of a number of recent research reports. Citigroup boosted their target price on Colgate-Palmolive from $105.00 to $110.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. UBS Group raised their price target on Colgate-Palmolive from $106.00 to $109.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Jefferies Financial Group reissued a “hold” rating on shares of Colgate-Palmolive in a report on Monday, August 3rd. Finally, The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. Twelve equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $99.00.

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 10,000 shares of the business’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $92.05, for a total transaction of $920,500.00. Following the completion of the transaction, the chief operating officer directly owned 64,901 shares in the company, valued at approximately $5,974,137.05. The trade was a 13.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 161,021 shares of the company’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $91.92, for a total value of $14,801,050.32. Following the completion of the sale, the chief executive officer directly owned 362,231 shares of the company’s stock, valued at approximately $33,296,273.52. This trade represents a 30.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 175,191 shares of company stock worth $16,110,903. Insiders own 0.43% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.